Ameriprise’s Molecular Templates, Inc. MTEM Stock Holding History

Ameriprise’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-7	Closed	-$4K	–	4540
2014 Q3	$4K	Buy	7 +1	+17%	+$692	﹤0.01%	5226
2014 Q2	$4K	Buy	+6	New	+$3.98K	﹤0.01%	5024
2013 Q4	–	Sell	-18	Closed	-$14K	–	5467
2013 Q3	$14K	Hold	18	–	–	﹤0.01%	4667
2013 Q2	$15K	Buy	+18	New	+$15.2K	﹤0.01%	4502

Other funds holding MTEM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise's MTEM Position: Q4 2014 in Review

Ameriprise sold out of Molecular Templates, Inc. (MTEM) in Q4 2014, closing a stake of 7 shares — an estimated $4K sold.

Ameriprise first reported a position in MTEM in Q2 2013 and held it in 4 quarters. The position peaked at $15K in Q2 2013. 83 funds tracked by Wall St. Rank hold MTEM as of Q4 2014.

Ameriprise reported no remaining Molecular Templates, Inc. position as of Q4 2014 after selling out during the quarter.
Ameriprise sold 7 Molecular Templates, Inc. shares in Q4 2014, an estimated $4K.
Ameriprise first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 4 quarters.
Ameriprise's Molecular Templates, Inc. position peaked at $15K in Q2 2013.
83 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.